Phase I trial of everolimus plus sorafenib for patients with advanced renal cell cancer.
about
Oncological Impact of M-Tor Inhibitor Immunosuppressive Therapy after Liver Transplantation for Hepatocellular Carcinoma: Review of the LiteratureTargeting Strategies for Renal Cell Carcinoma: From Renal Cancer Cells to Renal Cancer Stem CellsEvaluation of everolimus in renal cell cancer.Phase I combination of pazopanib and everolimus in PIK3CA mutation positive/PTEN loss patients with advanced solid tumors refractory to standard therapy.Phase I study of the combination of temsirolimus and pazopanib in advanced solid tumorsInefficiencies and Patient Burdens in the Development of the Targeted Cancer Drug Sorafenib: A Systematic ReviewSafety and feasibility of targeted agent combinations in solid tumours.Future perspectives for mTOR inhibitors in renal cell cancer treatment.A phase I study of cabozantinib (XL184) in patients with renal cell cancer.Lenvatinib for use in combination with everolimus for the treatment of patients with advanced renal cell carcinoma following one prior anti-angiogenic therapy.
P2860
Q28067445-C5AE75C2-9E09-415F-A1B6-62FFC206903BQ28078154-5110385C-85A4-44DC-9C29-85C7C0EE8232Q33407015-8EA3B49E-2DF5-4A8B-8B08-6F7CB4DFB1A9Q33422258-D76218D4-CD1E-45C0-8FA0-9B6E4CD9E495Q34129269-6B366F6C-39AC-43EF-A4C8-09B03180444EQ36270115-A6E1323F-C9DE-4EF4-9398-D4931E1D3BA7Q38077440-7C780651-FE53-4831-82E7-C5E2DFBEE515Q38372445-F7A91AEA-CA60-4407-8BDC-B43315C8FD1FQ38430335-7BC1F5F1-2EBD-4D73-9A44-A829F58CAF01Q38754614-320053B1-025C-47A0-8DDD-2CA1066DCFDE
P2860
Phase I trial of everolimus plus sorafenib for patients with advanced renal cell cancer.
description
2011 nî lūn-bûn
@nan
2011 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Phase I trial of everolimus plus sorafenib for patients with advanced renal cell cancer.
@ast
Phase I trial of everolimus plus sorafenib for patients with advanced renal cell cancer.
@en
type
label
Phase I trial of everolimus plus sorafenib for patients with advanced renal cell cancer.
@ast
Phase I trial of everolimus plus sorafenib for patients with advanced renal cell cancer.
@en
prefLabel
Phase I trial of everolimus plus sorafenib for patients with advanced renal cell cancer.
@ast
Phase I trial of everolimus plus sorafenib for patients with advanced renal cell cancer.
@en
P2093
P1476
Phase I trial of everolimus plus sorafenib for patients with advanced renal cell cancer.
@en
P2093
Amber L Flaherty
Mika Stepankiw
Robert J Amato
P356
10.1016/J.CLGC.2011.11.002
P407
P577
2011-12-13T00:00:00Z